Author:
Feldman H.,Scheltens P.,Scarpini E.,Hermann N.,Mesenbrink P.,Mancione L.,Tekin S.,Lane R.,Ferris S.
Abstract
The authors investigated neuropsychiatric symptoms in mild cognitive impairment (MCI) from baseline data of the Investigation in the Delay to Diagnosis of AD with Exelon (InDDEx) study (n = 1,010). Neuropsychiatric symptoms were reported in 59% of subjects (Neuropsychiatric Inventory [NPI]). NPI+ subjects had significantly greater impairment on global, cognitive, and functional scores than NPI− subjects. The presence of neuropsychiatric symptoms appears to be a marker of MCI severity.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
182 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献